Related Experiment Video
Updated: May 2, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
A snapshot of challenges and solutions in cancer drug development and therapy
1Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
Abstract:
Cancer chemotherapy has transitioned from the use of cytotoxic drugs to the era of agents with an apparent selectivity for a cancer-specific target. The past decade has provided evidence that therapy with such agents can be curative in subsets of patients. It is anticipated that incorporation of pharmacological principles for novel therapeutics will result in further refinement of outcome measures as well as the discovery of new treatment modalities for multiple malignant diseases.
Insights
Cancer chemotherapy has evolved from cytotoxic drugs to targeted agents. These targeted therapies show promise for curative outcomes in some cancer patients, signaling a new era in oncology.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Traditional chemotherapy relied on cytotoxic drugs with broad effects.
- Recent advancements focus on agents targeting specific cancer mechanisms.
- This shift represents a significant paradigm change in cancer treatment.
Discussion:
- The transition to targeted cancer therapy has demonstrated curative potential in specific patient groups.
- Understanding cancer-specific targets is crucial for developing effective treatments.
- Pharmacological principles guide the development and application of these novel agents.
Key Insights:
- Targeted cancer therapies offer improved selectivity over traditional cytotoxic drugs.
- Evidence suggests these agents can achieve cures in certain patient subsets.
- The integration of pharmacology is key to advancing targeted cancer treatments.
Outlook:
- Future cancer treatment will likely involve further refinement of targeted therapeutics.
- Novel treatment modalities for various malignant diseases are expected.
- Continued research in cancer pharmacology will drive therapeutic innovation.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
02:56Treatment Resistent Cancers
02:57Targeted Cancer Therapies
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:18Cancer